Biotech: venture funds and startups

◆ Funds tracked

131

◆ Combined AUM

$132.3B

◆ Startups tracked

60

◆ Raised between them

$532.8M

◆ Overview

Fusion42 tracks 131 venture funds in Biotech with $132.3B in combined assets under management, and 60 startups that have raised $532.8M between them. The data below is live from the same database that powers Raise and Scout, and is continuously enriched as new rounds and funds are announced.

Part of the Raise fund database and the Scout startup database by Fusion42 — the same live data Arthur reasons over.

◆ Highlights

Active funds in Biotech include Solari Capital, Forbion Growth Opportunities Fund IV and Forbion Ventures Fund VIII, NVM Ventures, Primo Biotech Lazio and Bain Capital Ventures Fund XI; startups in Biotech include BioLinker, SereNeuro Therapeutics, ZoeNCure Therapeutics, Pilgrim and Ordo Labs. Each name links through to a full machine-readable profile — its backers, rounds and related Wire analysis — and the tables below list every entity Fusion42 tracks in Biotech, refreshed as new rounds and funds are announced.

◆ Funds in Biotech (131 tracked)

◆ Startups in Biotech (60 tracked)

◆ Recent Wire analysis

• VERAXA Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant ...7 Oct 2026
• Life sciences firm Danaher to launch AI-powered autonomous research lab in 20277 Oct 2026
• Veraxa Biotech (VRXA) Advances FDA-Aligned NAMs to Accelerate Cl7 Oct 2026
• VERAXA Biotech implements FDA-aligned research models7 Oct 2026
• Veraxa Biotech implements FDA-aligned testing methods7 Oct 2026
• China's Pharma Industry Goes Global: From Low-Cost Generics to Innovative Biotech7 Oct 2026
• US firm ArriVent's plunge shows risks facing China's biotech expansion into global markets7 Oct 2026
• AbbVie, Genmab's Epkinly sets 'new standard of care' in first-line lymphoma in Phase 37 Oct 2026
• Compliance concerns hinder rollout of AI in drug manufacturing: Survey7 Oct 2026